Stay updated on Pembrolizumab for High Risk Oral Neoplasia Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab for High Risk Oral Neoplasia Clinical Trial page.

Latest updates to the Pembrolizumab for High Risk Oral Neoplasia Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe page now shows that recruitment is closed with the message 'No longer looking for participants'. New user guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) were added and the page revision was updated to v3.6.0, reflecting navigation refinements and a new version release.SummaryDifference0.4%

- Check18 days agoChange DetectedThe page's revision tag was updated from v3.5.4 to v3.5.5, indicating a minor update to the page's documentation or formatting.SummaryDifference0.1%

- Check40 days agoChange Detected- The page revision was updated from v3.5.3 to v3.5.4, reflecting a minor metadata update to the page.SummaryDifference0.1%

- Check61 days agoChange DetectedThis update reflects a change in the ClinicalTrials.gov page revision/version number from v3.5.2 to v3.5.3, indicating a site release rather than a modification to the study record itself.SummaryDifference0.1%

- Check68 days agoChange Detected- Revision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check97 days agoChange DetectedAdded site revision tag v3.5.0 and removed v3.4.3.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab for High Risk Oral Neoplasia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for High Risk Oral Neoplasia Clinical Trial page.